Fractional exhaled nitric oxide nonsuppression identifies corticosteroid-resistant type 2 signaling in severe asthma.

Author
Couillard, Simon
Shrimanker, Rahul
Chaudhuri, Rekha
Mansur, Adel H
McGarvey, Lorcan P
Heaney, Liam G
Fowler, Stephen J
Bradding, Peter
Pavord, Ian D
Hinks, Timothy S C
Publication date
2021-09-15
Subject
Respiratory medicine

Metadata
Show full item record
Abstract
No abstract available
Citation
Couillard S, Shrimanker R, Chaudhuri R, Mansur AH, McGarvey LP, Heaney LG, Fowler SJ, Bradding P, Pavord ID, Hinks TSC. Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma. Am J Respir Crit Care Med. 2021 Sep 15;204(6):731-734. doi: 10.1164/rccm.202104-1040LEa
Type
Article
Handle
http://hdl.handle.net/20.500.14200/4728
Additional Links
https://www.atsjournals.org/journal/ajrccm
DOI
10.1164/rccm.202104-1040LE
PMID
34129808
Journal
American Journal of Respiratory and Critical Care Medicine
Publisher
American Thoracic Society
Collections